Abstract
Get full access to this article
View all access options for this article.
References
1.
Duncan
CN
,
Bledsoe
JR
,
Grzywacz
B
, et al. Hematologic cancer after gene therapy for cerebral Adrenoleukodystroph . N Engl J Med , 2024 ; 391 (14 ):1287 –1301 ; doi: 10.1056/NEJMoa2405541 [Last accessed:
October 14 , 2024
].
2.
Mast
J
. 7 Children Developed Blood Cancer after Bluebird Bio gene Therapy for rare Neurological Disease . STAT , October 9, 2024 . Available from: https://www.statnews.com/2024/10/09/bluebird-bio-gene-therapy-blood-cancer-children/
3.Astellas Pharma and AviadoBio . Astellas and AviadoBio Announce Exclusive Option and License Agreement for Gene Therapy AVB-101 Targeting Frontotemporal Dementia and Other Indications . October 8, 2024 . Available from: https://aviadobio.com/astellas-and-aviadobio-announce-exclusive-option-and-license-agreement-for-gene-therapy-avb-101-targeting-frontotemporal-dementia-and-other-indications/ [Last accessed:
October 12 , 2024
].
4.MilliporeSigma . MilliporeSigma Opens New €290 Million Biosafety Testing Facility in Rockville, Maryland, USA . October 9, 2024 . Available from: https://www.sigmaaldrich.com/US/en/collections/press/new-biosafety-facility-rockville-md [Last accessed:
October 12 , 2024
].
5.
Davies
K
. MilliporeSigma Opens Glitzy $286 Million Biosafety Testing Facility in Maryland . Genetic Engineering & Biotechnology News . October 10, 2024 . Available from: https://www.genengnews.com/topics/bioprocessing/milliporesigma-opens-glitzy-286-million-biosafety-testing-facility-in-maryland/ [Last accessed:
October 12 , 2024
].
6.
Davies
K
. MilliporeSigma Opens Glitzy $286 Million Biosafety Testing Facility in Maryland . Genetic Engineering & Biotechnology News . October 10, 2024 . Available from: https://www.genengnews.com/topics/bioprocessing/milliporesigma-opens-glitzy-286-million-biosafety-testing-facility-in-maryland/ [Last accessed:
October 12 , 2024
].
7.Purespring Therapeutics . Purespring Therapeutics raises £80/$105 Million in a Series B Financing to Transform the Treatment of Kidney Diseases . October 9, 2024 . Available from: https://purespringtx.com/purespring-therapeutics-raises-80-105-million-in-a-series-b-financing-to-transform-the-treatment-of-kidney-diseases/ [Last accessed:
October 12 , 2024
].
8.GEMMA Biotherapeutics . GEMMABio Announces $100 Million Agreement with Brazil’s Leading Health Research Institute . October 8, 2024 . Available from: https://www.prnewswire.com/news-releases/gemmabio-announces-100-million-agreement-with-brazils-leading-health-research-institute-302270296.html [Last accessed:
October 12 , 2024
].
9.Nanoscope Therapeutics . Nanoscope Announces Plans to Submit BLA for MCO-010 to Treat Retinitis Pigmentosa . October 10, 2024 . Available from: https://nanostherapeutics.com/2024/10/10/nanoscope-announces-plans-to-submit-bla-for-mco-010-to-treat-retinitis-pigmentosa/ [Last accessed:
October 14 , 2024
].
10.Official website of Lithuania . Baltics’ First Gene Therapy Centre Officially Opens in Vilnius . September 26, 2024 . Available from: https://lithuania.lt/news/celltechna-first-gene-therapy-centre-in-the-baltic-states-officially-opens-in-vilnius/ [Last accessed:
October 14 , 2024
].